Uterine fibroids are the most common tumors of the female reproductive system and are mostly asymptomatic clinically. Asymptomatic fibroids usually do not require treatment, and some of them may shrink or recede after menopause. Patients can be further treated with ultrasound every 3-6 months if symptoms appear. Medication can be given for fibroids, but only for patients with mild clinical symptoms, nearing menopause, or whose medical condition does not allow surgery. Medication can relieve the symptoms, inhibit the growth of fibroids and make them shrink, but most fibroids will grow back to their original size after stopping medication. Some medications can cause menopausal syndrome or increase the risk of endometrial hyperplasia and are not recommended for long-term use. Surgery is the most effective treatment for uterine fibroids and is suitable for patients with symptoms or suspected malignant lesions. Surgery can be performed transabdominally, trans-laparoscopically, or hysteroscopically. Surgical modalities include myomectomy and hysterectomy. The exact modality depends on the patient’s condition. For patients who cannot be treated surgically for other reasons, uterine artery embolization can be chosen to reduce the blood supply to the fibroids, thus delaying their growth and relieving symptoms. Most fibroids are benign and have a low malignancy rate. Asymptomatic fibroids can be left untreated for the time being and can be reviewed regularly, while those with symptoms are advised to go to the hospital and communicate effectively with their doctors to choose a treatment plan that suits them.